These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8698522)

  • 1. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.
    Vecchiarelli A; Retini C; Monari C; Tascini C; Bistoni F; Kozel TR
    Infect Immun; 1996 Jul; 64(7):2846-9. PubMed ID: 8698522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
    Retini C; Vecchiarelli A; Monari C; Tascini C; Bistoni F; Kozel TR
    Infect Immun; 1996 Aug; 64(8):2897-903. PubMed ID: 8757810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.
    Vecchiarelli A; Retini C; Pietrella D; Monari C; Tascini C; Beccari T; Kozel TR
    Infect Immun; 1995 Aug; 63(8):2919-23. PubMed ID: 7622213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
    Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
    Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans.
    Retini C; Casadevall A; Pietrella D; Monari C; Palazzetti B; Vecchiarelli A
    J Immunol; 1999 Feb; 162(3):1618-23. PubMed ID: 9973421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.
    Pietrella D; Kozel TR; Monari C; Bistoni F; Vecchiarelli A
    J Infect Dis; 2001 Jan; 183(1):51-8. PubMed ID: 11087201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.
    Delfino D; Cianci L; Lupis E; Celeste A; Petrelli ML; CurrĂ³ F; Cusumano V; Teti G
    Infect Immun; 1997 Jun; 65(6):2454-6. PubMed ID: 9169790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
    Li RK; Mitchell TG
    J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor.
    Monari C; Kozel TR; Paganelli F; Pericolini E; Perito S; Bistoni F; Casadevall A; Vecchiarelli A
    J Immunol; 2006 Nov; 177(10):6842-51. PubMed ID: 17082598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.
    Blackstock R; Murphy JW
    Infect Immun; 1997 Oct; 65(10):4114-21. PubMed ID: 9317016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
    Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
    Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.
    Piccioni M; Monari C; Kenno S; Pericolini E; Gabrielli E; Pietrella D; Perito S; Bistoni F; Kozel TR; Vecchiarelli A
    Infect Immun; 2013 Jan; 81(1):90-8. PubMed ID: 23090956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses.
    Mariano Andrade R; Monteiro Almeida G; Alexandre DosReis G; Alves Melo Bento C
    Cell Immunol; 2003 Apr; 222(2):116-25. PubMed ID: 12826081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies.
    Vecchiarelli A
    Curr Mol Med; 2005 Jun; 5(4):413-20. PubMed ID: 15977997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.
    Vecchiarelli A; Retini C; Casadevall A; Monari C; Pietrella D; Kozel TR
    Infect Immun; 1998 Sep; 66(9):4324-30. PubMed ID: 9712784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
    Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
    Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.
    Chiapello LS; Baronetti JL; Aoki MP; Gea S; Rubinstein H; Masih DT
    Immunology; 2004 Nov; 113(3):392-400. PubMed ID: 15500627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes.
    Mody CH; Spurrell JC; Wood CJ
    J Infect Dis; 1998 Sep; 178(3):803-14. PubMed ID: 9728550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages.
    Monari C; Pericolini E; Bistoni G; Casadevall A; Kozel TR; Vecchiarelli A
    J Immunol; 2005 Mar; 174(6):3461-8. PubMed ID: 15749881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.